Ann-Kristin Erkens - Net Worth and Insider Trading
Ann-Kristin Erkens Net Worth
The estimated net worth of Ann-Kristin Erkens is at least $0 dollars as of 2024-09-25. Ann-Kristin Erkens is the Supervisory Board of Schott Pharma AG & CO KGaA and owns about 0 shares of Schott Pharma AG & CO KGaA (XTER:1SXP) stock worth over $0. Details can be seen in Ann-Kristin Erkens's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ann-Kristin Erkens has not made any transactions after 2023-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ann-Kristin Erkens
Ann-Kristin Erkens Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ann-Kristin Erkens owns 1 companies in total, including Schott Pharma AG & CO KGaA (XTER:1SXP) .
Click here to see the complete history of Ann-Kristin Erkens’s form 4 insider trades.
Insider Ownership Summary of Ann-Kristin Erkens
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XTER:1SXP | Schott Pharma AG & CO KGaA | 2023-10-02 | Supervisory Board |
Ann-Kristin Erkens Latest Holdings Summary
Ann-Kristin Erkens currently owns a total of 1 stock. Ann-Kristin Erkens owns 0 shares of Schott Pharma AG & CO KGaA (XTER:1SXP) as of October 2, 2023, with a value of $0.
Latest Holdings of Ann-Kristin Erkens
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XTER:1SXP | Schott Pharma AG & CO KGaA | 2023-10-02 | 0 | 30.50 | 0 |
Holding Weightings of Ann-Kristin Erkens
Ann-Kristin Erkens Form 4 Trading Tracker
According to the SEC Form 4 filings, Ann-Kristin Erkens has made a total of 1 transactions in Schott Pharma AG & CO KGaA (XTER:1SXP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Schott Pharma AG & CO KGaA is the acquisition of 1,755 shares on October 2, 2023, which cost Ann-Kristin Erkens around $47,385.
Insider Trading History of Ann-Kristin Erkens
- 1
Ann-Kristin Erkens Trading Performance
GuruFocus tracks the stock performance after each of Ann-Kristin Erkens's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ann-Kristin Erkens is 6.8%. GuruFocus also compares Ann-Kristin Erkens's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ann-Kristin Erkens within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ann-Kristin Erkens's insider trading performs compared to the benchmark.
Performance of Ann-Kristin Erkens
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.39 |  | | | | |
| Relative Return to S&P 500(%) | -10.08 | | | | | |
Ann-Kristin Erkens Ownership Network
Ann-Kristin Erkens Owned Company Details
What does Schott Pharma AG & CO KGaA do?
Who are the key executives at Schott Pharma AG & CO KGaA?
Ann-Kristin Erkens is the Supervisory Board of Schott Pharma AG & CO KGaA. Other key executives at Schott Pharma AG & CO KGaA include Supervisory Board Dr. Jens Schulte , Board of Directors Andreas Reisse , and Board of Directors Dr. Almuth Steinkühler .
Schott Pharma AG & CO KGaA (XTER:1SXP) Insider Trades Summary
Over the past 18 months, Ann-Kristin Erkens made 1 insider transaction in Schott Pharma AG & CO KGaA (XTER:1SXP) with a net purchase of 1,755. Other recent insider transactions involving Schott Pharma AG & CO KGaA (XTER:1SXP) include a net purchase of 1,509 shares made by Dr. Jens Schulte , a net purchase of 3,509 shares made by Andreas Reisse , and a net purchase of 1,852 shares made by Dr. Almuth Steinkühler .
In summary, during the past 3 months, insiders sold 0 shares of Schott Pharma AG & CO KGaA (XTER:1SXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,000 shares of Schott Pharma AG & CO KGaA (XTER:1SXP) were sold and 14,231 shares were bought by its insiders, resulting in a net purchase of 12,231 shares.
Schott Pharma AG & CO KGaA (XTER:1SXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Schott Pharma AG & CO KGaA Insider Transactions
Ann-Kristin Erkens Mailing Address
Above is the net worth, insider trading, and ownership report for Ann-Kristin Erkens. Currently GuruFocus does not have mailing address information for Ann-Kristin Erkens.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
